H2DCFDA ROS assay was carried out according to established protocols, with some adjustment (Supplemental Methods) (6 (link)). Cell toxicity was measured via ATP depletion (CellTiter Glo, Promega) in THLE-2 cells (ATCC, CRL-2706), following 72 hours of exposure to the test compounds, and cell viability was assessed using XTT assay (Biological Industries) according to manufacturers protocols. CETSA was performed as previously described (53 (link)) with some modifications, using QR2 (Santa Cruz, sc-271665) and SOD1 (Santa Cruz, sc-17767) antibodies. SDS-PAGE and immunoblot imaging were carried out as previously described (55 (link)), using Tubulin (Sigma-Aldrich, SAB4500087), QR2 (Santa Cruz, sc-271665), NDUFA9 (AbCam, ab14713) and CD73 (Cell Signaling Technology, D7F9A) antibodies.
Free full text: Click here